MTB
63
-2
COP
56
2
HRL
39
15
NTAP
64
2
EL
20
3
ORLY
53
-3
C
58
-2
ZBH
60
-2
PPL
54
2
BEN
45
3
SYK
64
-4
ILMN
32
-3
HON
65
-2
IPG
49
10
AA
51
3
TXT
48
2
INTU
51
2
AZO
46
-3
EQIX
60
-2
NWL
44
-4
MTB
63
-2
COP
56
2
HRL
39
15
NTAP
64
2
EL
20
3
ORLY
53
-3
C
58
-2
ZBH
60
-2
PPL
54
2
BEN
45
3
SYK
64
-4
ILMN
32
-3
HON
65
-2
IPG
49
10
AA
51
3
TXT
48
2
INTU
51
2
AZO
46
-3
EQIX
60
-2
NWL
44
-4
Financhill
Back

Dr Reddy's Laboratories 10K Form

Buy
52

RDY
Dr Reddy's Laboratories

Last Price:
14.02
Seasonality Move:
1.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.37B
Cash Flow: $16.69M
Price / Cash Flow: 116.44
Annual Sales: $4.38
Price / Book: 3.22

Profitability

EPS (TTM): 0.46660
Net Income (TTM): $651.82M
Gross Margin: $1.98B
Return on Equity: 19.35%
Return on Assets: 14.21%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 24 years for RDY is 58.61%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
  • The Research & Development expenses have been 8.19% of Revenue.
  • The Interest Expense is 3.07% of Operating Income.
  • The Net Earning history of RDY is 19.95% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.92
Quick Ratio: 1.28

Price-to-Earnings

Trailing P/E Ratio: 17.47
Forward P/E Ratio: 17.74

RDY Technical Analysis vs Fundamental Analysis

Buy
52
Dr Reddy's Laboratories (RDY) is a Buy

Is Dr Reddy's Laboratories a Buy or a Sell?